<DOC>
	<DOC>NCT00162721</DOC>
	<brief_summary>This is a Phase III study about the effects of the addition of polychemotherapy to adjuvant radiotherapy in the treatment of non-metastatic uterine sarcomas.</brief_summary>
	<brief_title>The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>Histologically confirmed uterine sarcoma (rereading in reference centers) Leiomyosarcoma, adenosarcoma, carcinosarcoma and high grade endometrial stromal sarcoma All stages &lt;= stage III (FIGO modified for endometrial carcinoma) Full surgical exeresis Age &gt;= 18 years and physiological age &lt;= 65 years Negative extension checkup (thoracic and abdominopelvic TDM) Performance status (PS) &lt;= 2 (ECOG) Normal haematologic functions (absolute neutrophil count &gt; 1,500/mm3, platelets &gt; 100,000/mm3) Serum creatinine &lt; 1.25 x ULN Good hepatic checkup (total serum bilirubin &lt; 1.5 x ULN; AST or ALT &lt; 2.5 x ULN) Absence of neuropathy &gt; grade 1 Left ventricular ejection fraction &gt; 50% (by isotopic or ultrasound scan determination) Written informed consent Low grade endometrial stromal sarcoma Time since surgery &gt; 8 weeks Specific contraindications to the studied treatment (cardiac, kidney, or hepatic ones) Antecedents or evolutive psychiatric disorder Concurrent active infection or other serious uncontrolled systemic disease Antecedents of cancer but a cutaneous basocellular one or an in situ epithelioma of the cervix</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Uterine sarcoma non metastatic</keyword>
</DOC>